Literature DB >> 7416744

In vitro susceptibility testing of Paracoccidioides brasiliensis to sulfonamides.

A Restrepo, M D Arango.   

Abstract

A total of 60 clinical isolates of Paracoccidioides brasiliensis were tested for susceptibility to sulfadiazine and sulfadimethoxyne by the agar dilution technique. A modification of the Mueller-Hinton medium was devised which gave good growth of the yeast form. The minimum inhibitory concentrations for only 51.6% of the isolates were in the range of the recommended blood serum concentration (50 micrograms/ml). For 6 to 8% of the isolates, the minimum inhibitory concentrations were above 200 micrograms of both sulfadiazine and sulfadimethoxyne per ml. A significant decreases in susceptibility was demonstrated for one isolate obtained from a patient relapsing during sulfonamide therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416744      PMCID: PMC283962          DOI: 10.1128/AAC.18.1.190

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  [The action of sulfamethoxypyridazine on some pathogenic aerobic actinomycetes].

Authors:  F MARIAT; J SATRE
Journal:  Bull Soc Pathol Exot Filiales       Date:  1961 Jan-Feb

2.  [Effect of sulfisoxazole on South American blastomycosis].

Authors:  S A SAMPAIO; C S DA LACAZ; H BOLOGNANI FILHO
Journal:  Rev Assoc Med Bras       Date:  1955-10       Impact factor: 1.209

3.  [Vitamin deficiencies of pathogenic fungi].

Authors:  A E de AREA LEAO; A CURY
Journal:  Mycopathol Mycol Appl       Date:  1950-03-25

4.  Miconazole in the treatment of systemic fungal infections.

Authors:  D Stevens
Journal:  Am Rev Respir Dis       Date:  1977-11

5.  [Our experiences with South American blastomycosis in Argentina].

Authors:  P Negroni; R Negroni
Journal:  Mycopathol Mycol Appl       Date:  1965-08-10

6.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  Nature of the skin-reactive principle in culture filtrates prepared from Paracoccidioides brasiliensis.

Authors:  A Restrepo-Moreno; J D Schneidau
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

8.  Reevaluation of the disk diffusion method for sulfonamide susceptibility testing of Neisseria meningitidis.

Authors:  S Hammerberg; M I Marks; G Weinmaster
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

9.  [Chemotherapy of South American blastomycosis; in vitro study of 4 aromatic diamidines, 2 sulphamides, 1 sulfone & 1 antihistaminic; clinical study of diamidinodiphenylamine].

Authors:  J E MACKINNON; A SANJINES; R C ARTAGAVEYTIA-ALLENDE
Journal:  An Fac Med Univ Repub Montev Urug       Date:  1957 Sep-Dec

10.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06
View more
  13 in total

1.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene.

Authors:  G San-Blas; F San-Blas; F Gil; L Mariño; R Apitz-Castro
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.

Authors:  D A Stevens; P T Vo
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

4.  Immunization with P10 peptide increases specific immunity and protects immunosuppressed BALB/c mice infected with virulent yeasts of Paracoccidioides brasiliensis.

Authors:  Julián E Muñoz; Vinicius D Luft; Juliana Amorim; Adriana Magalhães; Luciana Thomaz; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda
Journal:  Mycopathologia       Date:  2014-08-19       Impact factor: 2.574

5.  Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.

Authors:  André C Amaral; Alexandre F Marques; Julián E Muñoz; Anamélia L Bocca; Andreza R Simioni; Antonio C Tedesco; Paulo C Morais; Luiz R Travassos; Carlos P Taborda; Maria Sueli S Felipe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

6.  The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus.

Authors:  R Buissa-Filho; R Puccia; A F Marques; F A Pinto; J E Muñoz; J D Nosanchuk; L R Travassos; C P Taborda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

7.  Psoas abscesses caused by Paracoccidioides brasiliensis in an adolescent.

Authors:  Mariana Tresoldi Neves; Bruno Livani; William Dias Belangero; Antonia Teresinha Tresoldi; Ricardo Mendes Pereira
Journal:  Mycopathologia       Date:  2008-09-10       Impact factor: 2.574

Review 8.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

9.  Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

Authors:  Catarina J M Braga; Glauce M G Rittner; Julian E Muñoz Henao; Aline F Teixeira; Liliana M Massis; Maria E Sbrogio-Almeida; Carlos P Taborda; Luiz R Travassos; Luís C S Ferreira
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

10.  Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.

Authors:  R C Cruz; S M C Werneck; C S Oliveira; P C Santos; B M Soares; D A Santos; P S Cisalpino
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.